1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Chongqing Zhifei Biological Products Co., Ltd.
  6. Summary
    300122   CNE100000V20

CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

(300122)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-06-30
113.96 CNY   +2.66%
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
05/23Chongqing Zhifei Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021
CI
05/05UBS Adjusts Chongqing Zhifei Biological Products' Price Target to 163 Yuan From 175 Yuan, Keeps at Buy
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
108.95 108.88 109.5 111.01 113.96 Last
20628180 13442280 15989260 12820840 13012800 Volume
+8.20% -0.06% +0.57% +1.38% +2.66% Change
Estimated financial data (e)
Sales 2022 32 496 M 4 849 M 4 849 M
Net income 2022 7 649 M 1 142 M 1 142 M
Net cash position 2022 9 082 M 1 355 M 1 355 M
P/E ratio 2022 23,2x
Yield 2022 0,80%
Sales 2023 35 791 M 5 341 M 5 341 M
Net income 2023 8 966 M 1 338 M 1 338 M
Net cash position 2023 13 899 M 2 074 M 2 074 M
P/E ratio 2023 20,5x
Yield 2023 0,94%
Capitalization 182 B 27 210 M 27 210 M
EV / Sales 2022 5,33x
EV / Sales 2023 4,71x
Nbr of Employees 4 800
Free-Float 14,7%
More Financials
Company
Chongqing Zhifei Biological Products Co., Ltd. specializes in the research and development of vaccines for human use. The products include, in particular, bacterial vaccines for the prevention of meningitis, tuberculosis, rabies and influenza. 
Sector
Pharmaceuticals
Calendar
08/16Earnings Release
More about the company
Ratings of Chongqing Zhifei Biological Products Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
05/23Chongqing Zhifei Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021
CI
05/05UBS Adjusts Chongqing Zhifei Biological Products' Price Target to 163 Yuan From 175 Yua..
MT
04/28Zhifei Biological's Q1 Profit Surges 105% as Sales More Than Double
MT
04/28Chongqing Zhifei Biological Products Co., Ltd. Proposes Final Cash Dividend for the Yea..
CI
04/27Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Q..
CI
04/13Chongqing zhifei biological products co slumps more than 15%…
RE
03/03Zhifei Biological Wins Nod to Sell COVID-19 Vaccine in China; Shares Rise 3%
MT
03/01UBS Adjusts Chongqing Zhifei Biological Products' Price Target to 175 Yuan From 233 Yua..
MT
02/19China allows COVID boosters of different technologies than primary shots
RE
02/08Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Full Ye..
CI
2021Antibody response from China Zhifei's COVID shot weaker against Omicron
RE
2021Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
CI
2021CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Zhifei's COVID-19 Vaccine Wins Emergency-Use Approv..
MT
2021Zhifei-Biol Approves Election of Chen Xujiang and Gong Tao as Independent Directors
CI
More news
News in other languages on CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
05/23Chongqing Zhifei Biological Products Co., Ltd. approuve le dividende en espèces pour l'..
04/28Le bénéfice de Zhifei Biological au premier trimestre augmente de 105 % et les ventes f..
04/28Chongqing Zhifei Biological Products Co., Ltd. Propose un dividende final en espèces po..
04/27Chongqing Zhifei Biological Products Co., Ltd. annonce ses résultats pour le premier tr..
03/03Zhifei Biological obtient l'autorisation de vendre le vaccin COVID-19 en Chine ; les ac..
More news
Analyst Recommendations on CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
More recommendations
Chart CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Chongqing Zhifei Biological Products Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 113,96 CNY
Average target price 143,59 CNY
Spread / Average Target 26,0%
EPS Revisions
Managers and Directors
Ren Sheng Jiang Chairman & General Manager
Zhen Jing Li Chief Financial Officer
Yu Qin Wu Chairman-Supervisory Board
Bao Kui Liu Independent Director
Gang Deng Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-8.54%26 513
CSL LIMITED-7.45%89 299
SAMSUNG BIOLOGICS CO.,LTD.-13.51%43 398
WUXI BIOLOGICS (CAYMAN) INC.-22.42%38 605
BIOGEN INC.-15.00%29 867
UCB-19.64%15 947